Thomas Ichim

Thomas Ichim is the Chief Scientific Officer of Venvalo Group. Dr. Ichim is a seasoned biotechnology entrepreneur who dedicated over 20 years to launching, growing, and realizing value of multiple biotech companies. When he was eleven years old, his mother was diagnosed with Leukemia. This catalyzed Thomas’ complete dedication to biomedical sciences, with emphasis on practical implementation of advanced therapies. Dr. Ichim is especially renowned for his advances in regenerative medicine and immunotherapy. Dr. Ichim has led both small and large scientific teams, business development, and general executive functions. He has been a Manager, Vice President, as well as President and CEO of emerging biotechnology startups and billion-dollar public enterprises.